XML 65 R46.htm IDEA: XBRL DOCUMENT v3.24.1
FAIR VALUE MEASUREMENT - Narrative (Details)
$ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions
12 Months Ended
Mar. 02, 2021
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2023
$ / shares
Apr. 06, 2023
USD ($)
$ / shares
shares
Nov. 14, 2022
USD ($)
Nov. 14, 2022
CAD ($)
$ / shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Investment in unconsolidated entity   $ 11,000 $ 0        
Debt interest rate conversion feature   $ 872 1,320        
Derivative Asset, Statement of Financial Position [Extensible Enumeration]   SBH purchase option and other derivative assets          
Debt conversion option   $ 3,213 12,995        
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]   Derivative and other long-term liabilities          
Purchase option $ 8,000            
Purchase option, term 5 years            
Purchase option, extension term 2 years            
Percentage of outstanding shares 10.00%            
Warrants expiration period 60 days            
Loss on change in fair value of purchase option   $ 570 10,700        
Business combination, purchase option   1,730 2,300        
DeFloria, LLC              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Equity method ownership percentage         50.00%    
British American Tobacco | DeFloria, LLC              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Preferred units ownership percentage         100.00%    
AJNA Biosciences | DeFloria, LLC              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Equity method ownership percentage         50.00%    
DeFloria, LLC              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Preferred units (in shares) | shares         400,000    
Warrants outstanding (in shares) | shares         400,000    
Change in fair value of financial instruments   300          
Investment in unconsolidated entity   11,000          
DeFloria, LLC | Common Class A              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Class of warrant or right, number of securities called by warrants or rights (in shares) | shares         865,052    
Warrants exercise price (in cad or usd per share) | $ / shares         $ 2.89    
DeFloria, LLC | British American Tobacco              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Preferred units (in shares) | shares         200,000    
Capital contributed         $ 10,000    
DeFloria, LLC | AJNA Biosciences              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Preferred units (in shares) | shares         400,000    
Warrants outstanding (in shares) | shares         400,000    
Debt Conversion Option              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Unrealized gain (loss) on hedging instruments   10,080 3,082        
Debt conversion option   3,213 12,995        
Level 3              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Investment in unconsolidated entity   11,000          
Debt interest rate conversion feature   872 1,320        
Debt conversion option   0 0        
Business combination, purchase option   1,730 2,300        
Debt Interest Rate Conversion Feature              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Unrealized gain (loss) on hedging instruments   (471) 138        
BAT Group              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Convertible, ownership percentage of shares (as a percent)           19.90% 19.90%
Conversion price (in CAD per share) | $ / shares             $ 2.00
BAT Group | Minimum              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Accrued interest rate, percentage           5.00% 5.00%
BAT Group | Maximum              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Accrued interest rate, percentage           1.50% 1.50%
Convertible Notes Payable | BAT Group              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]              
Principal amount   $ 60,116 $ 56,080     $ 56,800 $ 75.3
Convertible, ownership percentage of shares (as a percent)   19.90%          
Conversion price (in CAD per share) | $ / shares       $ 2.00